Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Phase Two”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04224740
What this trial is testing

Pembrolizumab Combined With Cisplatin-based Chemotherapy as First-line Systemic Therapy in Advanced Penile Cancer

Who this might be right for
Penile Carcinoma
Latin American Cooperative Oncology Group 37
Testing effectiveness (Phase 2)Active Not RecruitingNCT00593840
What this trial is testing

Phase II Trial Evaluating Elimination of Radiation Therapy

Who this might be right for
Cancer of the Larynx
Washington University School of Medicine 74
Testing effectiveness (Phase 2)Ended earlyNCT00538291
What this trial is testing

Cetuximab and Capecitabine in Treating Patients With Metastatic Colorectal Cancer That Failed Irinotecan Treatment

Who this might be right for
Colorectal Cancer
City of Hope Medical Center 13
Testing effectiveness (Phase 2)Looking for participantsNCT06288191
What this trial is testing

Neoadjuvant Nivolumab and Relatlimab in Cutaneous Squamous Cell Carcinoma

Who this might be right for
Cutaneous Squamous Cell Carcinoma
Melanoma Institute Australia 20
Testing effectiveness (Phase 2)Study completedNCT02044874
What this trial is testing

Evaluate the Effect of Lorcaserin Hydrochloride on Smoking Cessation

Who this might be right for
Smoking Cessation
Arena Pharmaceuticals 603
Testing effectiveness (Phase 2)UnknownNCT05325190
What this trial is testing

Granisetron Transdermal Patch System for Prevention of CINV by CapeOX

Who this might be right for
Chemotherapy-induced Nausea and Vomiting
Tianjin Medical University Cancer Institute and Hospital 57
Not applicableStudy completedNCT04173897
What this trial is testing

Living Better With Advanced Breast Cancer: Feasibility Evaluation of an Online Supportive Intervention.

Who this might be right for
Metastatic Breast Cancer
University of Leeds 41
Testing effectiveness (Phase 2)Study completedNCT00882310
What this trial is testing

Gemzar, Taxotere, and Xeloda for Adjuvant Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Columbia University 37
Testing effectiveness (Phase 2)Study completedNCT02012582
What this trial is testing

Phase 2 a Study to Assess Safety and Pharmacokinetics of VAS203 in Patients With Traumatic Brain Injury

Who this might be right for
Traumatic Brain Injury
veriNOS operations GmbH 32
Not applicableActive Not RecruitingNCT06269913
What this trial is testing

A Novel Iron-Based Supplement for Athletes Aged 18-25: Phase II

Who this might be right for
Iron Deficiencies
University of Calgary 30
Testing effectiveness (Phase 2)Study completedNCT00748813
What this trial is testing

Safety and Immunogenicity of Surface Antigen, Inactivated, Influenza Vaccine Using the Strain Composition 2008/2009

Who this might be right for
Seasonal Influenza
Novartis Vaccines 133
Testing effectiveness (Phase 2)Ended earlyNCT03050060
What this trial is testing

Image Guided Hypofractionated Radiation Therapy, Nelfinavir Mesylate, Pembrolizumab, Nivolumab and Atezolizumab in Treating Patients With Advanced Melanoma, Lung, or Kidney Cancer

Who this might be right for
Metastatic Kidney CarcinomaRecurrent Lung Non-Small Cell CarcinomaStage IV Cutaneous Melanoma AJCC v6 and v7+2 more
University of Washington 21
Testing effectiveness (Phase 2)Study completedNCT02670616
What this trial is testing

Study of Ibrutinib in Combination With Rituximab-CHOP in Epstein-Barr Virus-positive Diffuse Large B-cell Lymphoma

Who this might be right for
Epstein-Barr Virus-positive Diffuse Large B-cell Lymphoma
Samsung Medical Center 24
Testing effectiveness (Phase 2)Study completedNCT00474916
What this trial is testing

Neuropathic Pain in Patients With Cancer

Who this might be right for
Neuropathic Pain
DARA Therapeutics 19
Testing effectiveness (Phase 2)Study completedNCT00250406
What this trial is testing

Assessment of Drug-eluting Ureteral Stent on Bacterial Adherence and Biofilm Formation

Who this might be right for
Renal CalculiUreteral Obstruction
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 20
Testing effectiveness (Phase 2)Looking for participantsNCT05753306
What this trial is testing

Robotic Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Treatment of Gastric Cancer With Limited Peritoneal Metastasis, ROBO-CHIP Study

Who this might be right for
Gastric AdenocarcinomaGastroesophageal Junction AdenocarcinomaMetastatic Malignant Neoplasm in the Peritoneum
Mayo Clinic 40
Testing effectiveness (Phase 2)Study completedNCT00899847
What this trial is testing

Phase 2 Study of Autologous Followed by Nonmyeloablative Allogeneic Transplantation Using TLI & ATG

Who this might be right for
Transplantation, HomologousTransplantation, AutologousMultiple Myeloma+1 more
Stanford University 9
Testing effectiveness (Phase 2)Ended earlyNCT02976038
What this trial is testing

Open-Label Extension Trial to Characterize the Long-term Safety and Tolerability of Elamipretide in Subjects With Genetically Confirmed Primary Mitochondrial Myopathy (PMM)

Who this might be right for
Primary Mitochondrial Disease
Stealth BioTherapeutics Inc. 28
Testing effectiveness (Phase 2)Looking for participantsNCT07392658
What this trial is testing

Phase II Trial of Amivantamab Plus Monochemotherapy in Platinum Unfit NSCLC Patients With EGFR exon20 Insertion Mutations.

Who this might be right for
Metastatic NSCLC - Non-Small Cell Lung Cancer
Fondazione Ricerca Traslazionale 33
Testing effectiveness (Phase 2)Ended earlyNCT00570258
What this trial is testing

Randomized, Double Blind Multicenter Phase II Study of Time to Progression on Fulvestrant in Combination With Erlotinib or Placebo in Hormone Receptor-Positive Metastatic Breast Cancer (MBC) Subjects Who Progressed on First Line Hormonal Therapy

Who this might be right for
Metastatic Breast Cancer
University of Arkansas 27
Next Page